Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination

Ahmad Shamsizadeh; Manoochehr Makvandi; Gholamali Shoshtari

Jundishapur Journal of Microbiology

Ahvaz Jundishapur University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination

Author(s):

Ahmad Shamsizadeh^1,*,

Manoochehr Makvandi²,

Gholamali Shoshtari²

1Jundishapur Infectious and Tropical Diseases Research Centre, and Abuzar Childrens Hospital, Ahvaz Jundishapur University of Medical Sciences, Shamsizadeh@ajums.ac.ir, Iran

2Jundishapur Infectious and Tropical Diseases Research Centre, Ahvaz Jundishapur University of Medical Sciences, Iran

Jundishapur Journal of Microbiology:Vol. 4, issue 1

Article type:Research Article

How to Cite:Ahmad ShamsizadehManoochehr MakvandiGholamali ShoshtariPrevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination.Jundishapur J Microbiol.4(1):null-null.

Abstract

Introduction and objective: The public vaccination program of hepatitis B virus was started in 1993 in Iran, and all children received three doses of hepatitis B vaccine in 0, 2 and 6 months of age routinely. The objective of this study was to determine the prevalence of antibody to hepatitis B surface (anti-HBs) five years after vaccination.

Materials and methods: In a cross-sectional study, anti-HBs was determined in six year old girl and boy students of selected elementary schools of Ahvaz with enzyme-linked immunosorbent assay (ELISA) method in 2006. All children had received complete course of hepatitis B vaccination in the first year of age.

Results: Four hundred and twenty seven students (223 girls and 204 boys) were enrolled in the study. Of them, 75.4% were anti-HBs positive (>10 mIU/mL). The prevalence of anti-HBs was statistically different between males and females (P=0.02).

Conclusion: The study detected anti-HBs in 75.4% of children and because of possibility of presence of anamnestic responses in seronegative subjects, a booster dose of vaccine is not necessary at least five years after primary vaccination. Further studies are needed to evaluate hepatitis B immunity in older age groups.

Keywords

Full Text

Full text is available in PDF

comments